(19)
(11) EP 2 328 613 A1

(12)

(43) Date of publication:
08.06.2011 Bulletin 2011/23

(21) Application number: 09782191.2

(22) Date of filing: 26.08.2009
(51) International Patent Classification (IPC): 
A61K 39/385(2006.01)
(86) International application number:
PCT/EP2009/060967
(87) International publication number:
WO 2010/023216 (04.03.2010 Gazette 2010/09)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
Designated Extension States:
AL BA RS

(30) Priority: 28.08.2008 US 92582 P
15.10.2008 US 95747 P
01.04.2009 US 165688 P

(71) Applicant: GlaxoSmithKline Biologicals S.A.
1330 Rixensart (BE)

(72) Inventors:
  • BIEMANS, Ralph Leon
    B-1330 Rixensart (BE)
  • ELOUAHABI, Abdelatif
    B-1330 Rixensart (BE)

(74) Representative: Robertson, James Stuart 
GlaxoSmithKline Global Patents CN925.1 980 Great West Road
Brenford Middlesex TW8 9GS
Brenford Middlesex TW8 9GS (GB)

   


(54) VACCINE